GENETICS AND ENVIRONMENTAL FACTORS OF GLAUCOMA & MYOPIA
Professor David Mackey AO,
Professor of Ophthalmology
The Lions Eye Institute,
University of Western Australia
RESEARCHER PROFILE
Filmed in Perth, Western Australia | February 2026
Professor David Mackey, AO is a clinician, scientist and academic. He is Professor of Ophthalmology at UWA and was the Lions Eye Institute’s Managing Director from 2009 until 2018.
A University of Tasmania medical graduate, Professor Mackey completed his ophthalmology training at the Royal Victorian Eye and Ear Hospital in Melbourne. After an MD thesis on Leber Hereditary Optic Neuropathy at the University of Melbourne, he completed fellowships in the US and UK in genetic eye diseases.
A renowned international researcher on the genetics of eye disease, Professor Mackey leads the Lions Eye Institute’s Genetics and Epidemiology research group, which pursues multiple projects aimed at understanding how genes and environment interact to influence an individual’s risk of eye disease.
Professor Mackey collaborates with researchers worldwide. He is a lead investigator in the International Glaucoma Genetics Consortium (IGCC) and the Consortium for Refractive Error and Myopia (CREAM). In the 1990s he coordinated an international consortium across eight countries to establish the frequency of Leber Hereditary Optic Neuropathy (LHON) mutations.
In Australia, he initiated the Glaucoma Inheritance Study in Tasmania – creating one of the largest glaucoma biobanks in the world and contributing to the discovery of more than a dozen genes associated with Mendelian genetic eye disease.
The Twins Eye Study in Tasmania and Brisbane, the Norfolk Island Eye Study, the eye component of the WA Pregnancy (Raine) Cohort, Busselton Healthy Aging Study are his other major projects.
Professor Mackey’s original research, over more than 30 years into the genetics of glaucoma and in the fields of optic atrophy and congenital cataract, has received constant professional accolades, attracted ongoing research funding and led to his publication of more than 400 peer-reviewed papers.
In 2019, he was made an Officer (AO) in the General Division of the Order of Australia for “distinguished service to medicine, and to medical education, in the field of ophthalmology, as a clinician-scientist and academic”.
Source: Lions Eye Institute website
https://orcid.org/0000-0001-7914-4709
-
Impact of NextSense Institute Research in the field of sensory disabilities
NextSense has a 165 year history of providing services and education for individuals with sensory impairments. With the support of donations, NextSense provides vital support for children and adults, more cochlear implants than any other service in Australia, and is a world leader for research, technology and professional education in the fields of visions and hearing loss.
NextSense clinicians are actively involved in a number of leading research projects—both independently and in collaboration with local and international organisations. The NextSense Institute, part of NextSense is Australia’s leading centre for research and professional education in the field of sensory disabilities.
-
Newborn screening for congenital hypothyroidism
Assoc Prof Jack is passionate about the health and wellbeing of children and adolescents, with diverse research areas including the impacts of family friendly workplace initiatives, screening and management of thyroid disorders in infants and children. She supports her First Nations colleagues on Indigenous-led research projects funded by the Medical Research Future Fund, aiming to improve the social and emotional wellbeing of First Nations Children. Through her clinical and academic roles, Assoc Prof Jack hopes to make a positive difference to the health and well-being of children and their families.
-
Development of novel analytical and diagnostic tools using nanotechnology and microfluidics
Dr Alain Wuethrich is an NHMRC Emerging Leader fellow and ARC DECRA awardee at the Australian Institute for Bioengineering and Nanotechnology.
Hailing from Switzerland, research focuses on the development of novel analytical and diagnostic tools that harness nanotechnology and microfluidics; two rapidly growing fields with high potential to provide diagnostic solutions needed for precision medicine.
